RNVU1-28

Across TCGA pan-cancer cohorts, RNVU1-28 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNVU1-28 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNVU1-28 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNVU1-28 expression acts as an unfavorable survival marker, although some lineages such as LGG and CESC show a favorable association.

THCA, LGG, and ACC are the cancer types where RNVU1-28 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	All	0.880	0.942	.002	48	view →
LGG	DFS	Tertile	All	0.550	0.348	<.001	37	view →
ACC	OS	Tertile	IV	0.400	0.746	.004	33	view →
BRCA	DFS	Tertile	All	0.908	0.953	.016	24	view →
ESCA	OS	Tertile	All	0.418	0.663	.010	21	view →
CESC	DFS	Tertile	All	0.765	0.504	.037	18	view →
LUAD	OS	Tertile	IV	0.114	0.560	.038	18	view →
SKCM	OS	Tertile	IV	0.247	0.721	.038	9	view →
DLBC	DFS	Median	IV	1.000	0.510	.030	3	view →
TGCT	DFS	Quartile	All	0.713	0.853	.040	2	view →
LAML	DFS	Quartile	All	0.791	0.516	.035	2	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNVU1-28–THCA (DFS)

Open the THCA breakdown →